These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 36115592)
1. High Bulk-Density Amorphous Dispersions to Enable Direct Compression of Reduced Tablet Size Amorphous Dosage Units. Frank DS; Nie H; Chandra A; Coelho A; Dalton C; Dvorak H; Elkhabaz A; Fahy M; Ormes J; Parker A; Punia A; Rowe J; Schenck L; Smith D; Strotman NA; Wang M; Wareham L J Pharm Sci; 2023 Aug; 112(8):2037-2045. PubMed ID: 36115592 [TBL] [Abstract][Full Text] [Related]
2. A Comparison of Spray-Drying and Co-Precipitation for the Generation of Amorphous Solid Dispersions (ASDs) of Hydrochlorothiazide and Simvastatin. Myślińska M; Stocker MW; Ferguson S; Healy AM J Pharm Sci; 2023 Aug; 112(8):2097-2114. PubMed ID: 36805392 [TBL] [Abstract][Full Text] [Related]
4. Detrimental Effect of the Film Coat Chemistry and Thickness on the Physical Stability of Amorphous Solid Dispersions in Tablet Formulations. Punia A; Biyyala V; Faassen F; Ash J; Lamm MS J Pharm Sci; 2023 Mar; 112(3):708-717. PubMed ID: 36189478 [TBL] [Abstract][Full Text] [Related]
5. Densifying Co-Precipitated Amorphous Dispersions to Achieve Improved Bulk Powder Properties. Frank DS; Punia A; Fahy M; Dalton C; Rowe J; Schenck L Pharm Res; 2022 Dec; 39(12):3197-3208. PubMed ID: 36271203 [TBL] [Abstract][Full Text] [Related]
6. Evaluating Spray Drying and Co-Precipitation as Manufacturing Processes for Amorphous Solid Dispersions of a Low T Solomos MA; Punia A; Saboo S; John C; Boyce CW; Chin A; Taggart RV; Smith D; Lamm MS; Schenck L J Pharm Sci; 2023 Aug; 112(8):2087-2096. PubMed ID: 36822272 [TBL] [Abstract][Full Text] [Related]
7. Building a better particle: Leveraging physicochemical understanding of amorphous solid dispersions and a hierarchical particle approach for improved delivery at high drug loadings. Schenck L; Mann AKP; Liu Z; Milewski M; Zhang S; Ren J; Dewitt K; Hermans A; Cote A Int J Pharm; 2019 Mar; 559():147-155. PubMed ID: 30654058 [TBL] [Abstract][Full Text] [Related]
8. The impact of diluents on the compaction, dissolution, and physical stability of amorphous solid dispersion tablets. Yu D; Hoag SW Int J Pharm; 2024 Apr; 654():123924. PubMed ID: 38395318 [TBL] [Abstract][Full Text] [Related]
9. Assessing the Interrelationship of Microstructure, Properties, Drug Release Performance, and Preparation Process for Amorphous Solid Dispersions Via Noninvasive Imaging Analytics and Material Characterization. Jia W; Yawman PD; Pandya KM; Sluga K; Ng T; Kou D; Nagapudi K; Luner PE; Zhu A; Zhang S; Hou HH Pharm Res; 2022 Dec; 39(12):3137-3154. PubMed ID: 35661085 [TBL] [Abstract][Full Text] [Related]
10. Impact of drug loading on the compaction properties of itraconazole-PVPVA amorphous solid dispersions. Zhang W; Sluga KK; Yost E; Phan J; Nagapudi K; Helen Hou H Int J Pharm; 2022 Dec; 629():122366. PubMed ID: 36336201 [TBL] [Abstract][Full Text] [Related]
11. Compression of amorphous solid dispersions prepared by hot-melt extrusion, spray drying and vacuum drum drying. Schönfeld BV; Westedt U; Wagner KG Int J Pharm X; 2021 Dec; 3():100102. PubMed ID: 34877525 [TBL] [Abstract][Full Text] [Related]
12. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance. Indulkar AS; Lou X; Zhang GGZ; Taylor LS Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846 [TBL] [Abstract][Full Text] [Related]
13. Hierarchical Particle Approach for Co-Precipitated Amorphous Solid Dispersions for Use in Preclinical In Vivo Studies. Schenck L; Boyce C; Frank D; Koranne S; Ferguson HM; Strotman N Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371726 [TBL] [Abstract][Full Text] [Related]
14. Improving Dissolution Performance and Drug Loading of Amorphous Dispersions Through a Hierarchical Particle Approach. Hiew TN; Saboo S; Zemlyanov DY; Punia A; Wang M; Smith D; Lowinger M; Solomos MA; Schenck L; Taylor LS J Pharm Sci; 2023 Aug; 112(8):2057-2068. PubMed ID: 36574837 [TBL] [Abstract][Full Text] [Related]
15. Downstream processing of spray-dried ASD with hypromellose acetate succinate - Roller compaction and subsequent compression into high ASD load tablets. Sauer A; Warashina S; Mishra SM; Lesser I; Kirchhöfer K Int J Pharm X; 2021 Dec; 3():100099. PubMed ID: 34765966 [TBL] [Abstract][Full Text] [Related]
16. Effects of tablet formulation and subsequent film coating on the supersaturated dissolution behavior of amorphous solid dispersions. Sakai T; Hirai D; Kimura SI; Iwao Y; Itai S Int J Pharm; 2018 Apr; 540(1-2):171-177. PubMed ID: 29447848 [TBL] [Abstract][Full Text] [Related]
17. Investigating the effects of formulation variables on the disintegration of spray dried amorphous solid dispersion tablets. Zhang W; Thool P; Weitz BW; Hou HH J Pharm Sci; 2024 Oct; ():. PubMed ID: 39374694 [TBL] [Abstract][Full Text] [Related]
18. A Fundamental Study on Compression Properties and Strain Rate Sensitivity of Spray-Dried Amorphous Solid Dispersions. Doktorovová S; Stone EH; Henriques J AAPS PharmSciTech; 2022 Mar; 23(4):96. PubMed ID: 35314895 [TBL] [Abstract][Full Text] [Related]
19. Effect of Spray-Dried Particle Morphology on Mechanical and Flow Properties of Felodipine in PVP VA Amorphous Solid Dispersions. Ekdahl A; Mudie D; Malewski D; Amidon G; Goodwin A J Pharm Sci; 2019 Nov; 108(11):3657-3666. PubMed ID: 31446144 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive evaluation of polymer types and ratios in Spray-Dried Dispersions: Compaction, Dissolution, and physical stability. Yu D; Nie H; Hoag SW Int J Pharm; 2024 Jan; 650():123674. PubMed ID: 38061497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]